Our Disease Areas
We target diverse diseases with innovative RNA therapeutics, offering hope to patients with chronic and debilitating conditions.
Type 2 Diabetes
Type 2 diabetes (T2D) is a chronic, metabolic disease in which blood sugar levels become elevated due to the body’s cells becoming resistant to insulin.
Our Pipeline
“This would be a new RNA therapy for type 2 diabetes, with the potential to improve glucose control and reduce the burden of disease.”
-Dr. Bu Yeap, Clinical Advisor
